These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7713806)

  • 1. Refractory ceramic fibers activate alveolar macrophage eicosanoid and cytokine release.
    Leikauf GD; Fink SP; Miller ML; Lockey JE; Driscoll KE
    J Appl Physiol (1985); 1995 Jan; 78(1):164-71. PubMed ID: 7713806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Autoregulatory role of leukotriene B4.
    Dubois CM; Bissonnette E; Rola-Pleszczynski M
    Am Rev Respir Dis; 1989 May; 139(5):1257-64. PubMed ID: 2540688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolar macrophage cytokine and growth factor production in a rat model of crocidolite-induced pulmonary inflammation and fibrosis.
    Driscoll KE; Maurer JK; Higgins J; Poynter J
    J Toxicol Environ Health; 1995 Oct; 46(2):155-69. PubMed ID: 7563215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory and fibrotic mediator release by alveolar macrophages from coal miners.
    Kuhn DC; Stauffer JL; Gaydos LJ; Demers LM
    J Toxicol Environ Health; 1995 Sep; 46(1):9-21. PubMed ID: 7666496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of mineral dust surface chemistry on eicosanoid production by the alveolar macrophage.
    Kuhn DC; Demers LM
    J Toxicol Environ Health; 1992 Jan; 35(1):39-50. PubMed ID: 1309464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced release of leukotrienes B4 and C4 from alveolar macrophages of rats with silicosis.
    Mohr C; Davis GS; Graebner C; Amann S; Hemenway DR; Gemsa D
    Am J Respir Cell Mol Biol; 1992 Nov; 7(5):542-7. PubMed ID: 1329867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of surfactant on basal and silica-induced eicosanoid production by the alveolar macrophage.
    Kuhn DC; Demers LM
    Am J Physiol; 1995 Aug; 269(2 Pt 1):L165-70. PubMed ID: 7653576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of eicosanoid production by human alveolar macrophages exposed to silica in vitro.
    Koren HS; Joyce M; Devlin RB; Becker S; Driscoll K; Madden MC
    Environ Health Perspect; 1992 Jul; 97():77-83. PubMed ID: 1327740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term inhalation and in vitro tests as predictors of fiber pathogenicity.
    Cullen RT; Miller BG; Davis JM; Brown DM; Donaldson K
    Environ Health Perspect; 1997 Sep; 105 Suppl 5(Suppl 5):1235-40. PubMed ID: 9400730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
    Sayes CM; Reed KL; Warheit DB
    Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered release of eicosanoids by rat alveolar macrophages during granulomatous pulmonary inflammation.
    Shellito J; Sniezek M
    Am J Respir Cell Mol Biol; 1990 Mar; 2(3):289-96. PubMed ID: 2155633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional NO2 exposure induces a decrease in cytokine specific mRNA expression and cytokine release of particle and fibre exposed human alveolar macrophages.
    Drumm K; Buhl R; Kienast K
    Eur J Med Res; 1999 Feb; 4(2):59-66. PubMed ID: 10066641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary response to silica or titanium dioxide: inflammatory cells, alveolar macrophage-derived cytokines, and histopathology.
    Driscoll KE; Lindenschmidt RC; Maurer JK; Higgins JM; Ridder G
    Am J Respir Cell Mol Biol; 1990 Apr; 2(4):381-90. PubMed ID: 2157474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue injury following inhalation of fine particulate matter and hydrogen peroxide is associated with altered production of inflammatory mediators and antioxidants by alveolar macrophages.
    Morio LA; Hooper KA; Brittingham J; Li TH; Gordon RE; Turpin BJ; Laskin DL
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):188-99. PubMed ID: 11749118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous nitric oxide inhibits leukotriene B4 release from rat alveolar macrophages.
    Brunn G; Hey C; Wessler I; Racké K
    Eur J Pharmacol; 1997 May; 326(1):53-60. PubMed ID: 9178655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4.
    Garcia JG; Griffith DE; Cohen AB; Callahan KS
    Am Rev Respir Dis; 1989 Jun; 139(6):1494-501. PubMed ID: 2543249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of mineral dusts on the in vitro activation of alveolar macrophage eicosanoid and cytokine release.
    Driscoll KE; Higgins JM; Leytart MJ; Crosby LL
    Toxicol In Vitro; 1990; 4(4-5):284-8. PubMed ID: 20702179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis.
    De Rose V; Trentin L; Crivellari MT; Cipriani A; Gialdroni Grassi G; Pozzi E; Folco G; Semenzato G
    Thorax; 1997 Jan; 52(1):76-83. PubMed ID: 9039241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished arachidonic acid metabolite release by bovine alveolar macrophages exposed to surface-modified silica.
    Englen MD; Taylor SM; Laegreid WW; Silflow RM; Leid RW
    Am J Respir Cell Mol Biol; 1992 May; 6(5):527-34. PubMed ID: 1316133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal degradation events as health hazards: particle vs gas phase effects, mechanistic studies with particles.
    Oberdörster G; Ferin J; Finkelstein J; Soderholm S
    Acta Astronaut; 1992; 27():251-6. PubMed ID: 11537569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.